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ABSTRACT  
Background   
Psoriasis is a common long-term, immune-mediated skin condition associated with behavioural 
factors (e.g. smoking, excess alcohol, obesity) which increase the risk of psoriasis onset, flares, and 
comorbidities. Motivational interviewing (MI) is an evidence-based approach to health-related 
behaviour change that has been used successfully with patients with long-term conditions. This 
study assessed change in clinicians’ MI skills and psoriasis knowledge following Psoriasis and Well-
being (Pso Well®) training.      
Objectives  
(1) To investigate whether the Pso Well® training intervention improves clinicians’ MI skills and 
knowledge about psoriasis-related comorbidities and risk factors.  
(2) To explore the acceptability and feasibility of the Pso Well® training content, delivery and evaluation. 
What is already known about this topic? 
• Holistic care of people with psoriasis requires knowledge about and management 
of co-morbidities and associated risk factors. 
• Motivational interviewing can support people with long-term conditions to make 
necessary changes to health-related behaviours.  
What does this study add? 
• The first evaluation of motivational interviewing skills training for clinicians 
managing psoriasis patients. 
• Psoriasis-tailored motivational interviewing training assists clinicians to manage 
psoriasis holistically and support behaviour change. 
• The Pso Well® training is acceptable to clinicians and feasible to run within UK 
healthcare settings 
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Methods   
Clinicians attended the 1-day training programme focused on MI skills development in the context of 
psoriasis. MI skills were assessed pre- and post-training using the Behaviour Change Counselling 
Index. Knowledge about psoriasis-related comorbidity and risk factors was assessed with a novel 22-
point measure developed for the study. Interviews with clinicians were analysed qualitatively to 
identify perceptions about feasibility and acceptability of the training.   
Results    
Sixty-one clinicians completed the training (35 dermatology nurses; 23 dermatologists; 3 primary 
care clinicians). Clinicians’ MI skills (p<.001) and knowledge (p< .001) increased significantly post-
training. Clinicians found the training valuable and relevant to psoriasis management. 
Conclusions   
Attendance at the Pso Well® training resulted in improvements in clinicians’ knowledge and skills to 
manage psoriasis holistically. Clinicians deemed the training itself and the assessment procedures 
used both feasible and acceptable. Future research should investigate how this training may 
influence patient outcomes.  
 
BACKGROUND 
Psoriasis is a complex immune-mediated skin condition affecting approximately 2% of the UK 
population1. Associations between psoriasis and other physical and psychological comorbidities are 
well established including cardiovascular disease (CVD), metabolic disease, and diabetes2,3; psoriatic 
arthritis (PsA)4; Crohn’s disease5; anxiety, depression and suicidality6. Behavioural factors that 
increase individuals’ risk of developing or exacerbating psoriasis and its comorbidities include 
smoking7-9, obesity8-12, physical inactivity13,14, excess alcohol consumption15-18, and poor medication 
adherence19-21. Psychological distress related to living with psoriasis may also limit an individual’s 
quality of life and capacity for effective self-management17, 21-25.  
Holistic psoriasis management therefore requires understanding of the relationships between 
psoriasis, distress, and behavioural factors26 as well as the skills to help patients achieve behavioural 
changes. Behavioural change is notoriously difficult27 and our earlier studies demonstrated that 
clinicians working with people with psoriasis miss opportunities to address behaviour change topics 
within clinical consultations28,29. Clinicians also report lacking confidence and skills to address 
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lifestyle behaviour change in psoriasis consultations28-30; and view psoriasis as a simple skin condition 
rather than a complex long-term condition requiring integrated management of behavioural 
factors26,30,31. We therefore developed 1-day training for clinicians to manage psoriasis and support 
patient behaviour change within standard dermatology consultations.  
The UK’s Medical Research Council (MRC) guidelines advocate an iterative approach to the 
development of complex interventions in which design and evaluation inform one another, moving 
from exploratory studies to more definitive evaluation phases32. Resulting interventions are more 
likely to be effective and implementable within a target care setting due to the process of evidence-
based evaluation/revision. Trials of such interventions are also less likely to fail due to problems of 
acceptability, intervention delivery or insensitivity to local context32. As an initial step in this process, 
we assessed whether clinicians acquire new psoriasis management skills following attendance at this 
training programme.   
Motivational Interviewing (MI) is an evidence-based approach that strengthens motivation to 
change health-behaviours by eliciting people’s beliefs about change, collaboratively developing 
goals, and increasing confidence to achieve change33,34. MI techniques typically foster people’s 
motivations for change by asking them to identify personal reasons, ability, or desires to change; 
reducing opposition to change by acknowledging barriers and facilitators to making this change; and 
by reflecting personal strengths and previous examples of engaging in behaviour change. MI has 
successfully supported individuals to change behaviours across health contexts including in 
substance addiction, and long-term conditions (LCTs), including psoriasis33,35-39. No study has 
evaluated the effectiveness of MI training tailored to clinicians working with people with psoriasis, or 
conducted process evaluations to explore factors potentially influencing training efficacy and uptake 
(e.g. via clinicians’ perspectives on training relevance and utility).  
The Psoriasis and Wellbeing (Pso Well®) training programme provided clinicians with skills to support 
behaviour change with psoriasis patients. It also aimed to increase clinicians’ knowledge about the 
relationships between psoriasis and risk factors for psoriasis-related comorbidities or worse psoriasis 
outcomes, given previous research indicating limited knowledge in this area26. This exploratory study 
investigated the following question: Can the Pso Well® training provide clinicians with the skills to 
address behavioural risk factors in psoriasis, and increase knowledge about the relationships 
between psoriasis and its comorbidities? We hypothesised that following training clinicians would 
acquire MI skills to support behaviour change with patients and knowledge about psoriasis-related 
comorbidities and risk factors. 
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METHODS 
Design 
This before and after, exploratory investigation of a 1-day training programme was conducted in 
small groups of clinicians from a range of practice settings. An embedded qualitative study was used 
to explore clinicians’ experiences and perceptions of the training. Institutional research ethics 
approval was obtained (ref: 14223). 
 
Participant recruitment 
UK primary and secondary care clinicians involved in psoriasis management were invited to 
participate in the study via email/letter/phone. Recruitment sources included: British Association of 
Dermatologists, Scottish and Welsh Dermatological Societies, Primary Care Dermatology Society, 
local primary care Clinical Commissioning Groups, nurse specialist groups (British Dermatological 
Nursing Group, National Dermatology Specialist Nurses meeting; established dermatology 
departments across Wales, England and Scotland), and local research events.  
 
Measures 
Clinicians’ motivational interviewing skills  
The Behaviour Change Counselling Index (BECCI) is a valid and reliable 11-item skills checklist that 
assesses core MI competencies40. Clinicians participated in two, 10-minute audio-taped 
consultations with trained and experienced patient actors, immediately before and immediately 
after the Pso Well® training. Four patient actors (2 male; 2 female), were used to standardise the 
assessment delivery. Scripts provided to patient actors were developed by members of the research 
team to form anonymous, composite patient cases, with content based on both clinical experience 
and patient research. Scripts were standardised for length and depth of content, as well as the 
number and type of cues about behavioural risk factors (e.g. obesity, alcohol, low mood) that 
patients would provide during assessments.  
Completed audio-recordings were reviewed by an independent panel of seven trained BECCI raters 
from psychology, health economics, health care and health services research. Raters were trained by 
AC/CB (experienced MI trainers) during three standardisation meetings to calibrate approaches to 
scoring and then blinded to pre- and post-training audio tapes. The team was assessed for inter-
rater reliability by comparing two audio-recordings each against a ‘gold standard’ scorer (MI trainer). 
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Intraclass correlation coefficients (ICCs) indicated ‘almost perfect’ agreement41 on Mean BECCI score 
(ICC = .93, 95% confidence interval [CI] = .75 - .98, p<.001) and Total BECCI score (ICC = .93, 95% CI = 
.77-.98, p<.001). The primary outcome was change in clinicians’ BECCI score. A change of 0.8 
between the before and after score was considered adequate to measure responsiveness on this 
measure40, although the study was initially powered to detect a change of 0.4. To have 80% power 
to detect this change as statistically significant at the 5% level required a minimum sample size of 41 
clinicians. 
Clinicians working with an MI approach are expected to talk less than patients (i.e. <50% of total 
consultations time), therefore, BECCI raters also estimated the percentage of time that clinicians 
talked during consultations compared to patients. Coders’ estimates of ‘talk time’ were compared 
with objectively calculated ‘talk time’ throughout training to optimise consistency with actual 
clinician ‘talk time’. This measure is recommended as a supplementary indicator of an MI-consistent 
consultation approach40.  
 
Patient actors participating in consultations with clinicians provided written feedback on their 
evaluation of clinicians’ skills pre- and post-training using a five-point Likert scale (with 5 items) plus 
open text responses which were categorised with content analysis. Likert scale items addressed the 
degree to which patient actors felt i) listened to in the consultation; ii) the clinician understood how 
they were feeling; iii) confident to make behavioural changes following the consultation; iv) that the 
clinician provided constructive information; and v) they talked more than the clinician about ways to 
improve their health.  
 
Knowledge of psoriasis-related comorbidities and risk factors 
A 22-item survey assessing current knowledge about psoriasis-related comorbidities and risk factors 
was devised for this study by experts in psoriasis and its comorbidities, and checked for accuracy and 
ease or difficulty of comprehension with the wider research team. The survey assessed knowledge 
about (a) psoriasis-related comorbidities; (b) prevalence of behavioural (smoking, alcohol, obesity, 
physical inactivity) and mood (anxiety, depression, stress) factors in psoriasis; (c) associations 
between psoriasis and behavioural and mood factors. Maximum scores were 9 points, 19 points and 
7 points (respectively); the total maximum score was 35. 
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To assess the degree to which clinicians applied their knowledge of psoriasis-related risk factors in 
consultations with patient-actors in a simulated practice setting, the audio-recorded consultations 
were coded for two additional items. First, researchers scored the clinicians from 0 (not at all) to 4 (a 
great extent) on the question: Did the clinician make links between psoriasis and behaviour change 
topics?  Second, raters were asked to note the ‘behaviour change topics’ arising during 10-minute 
consultations to capture the range and type of topics clinicians chose to discuss with patients before 
and after training.  
 
Analysis  
Descriptive analyses were conducted on participant demographics and the frequency and range of 
topics discussed during audio-recorded consultations. Primary outcome measures (BECCI skills and 
knowledge survey) were analysed using within group comparisons (paired-samples t-tests and 
Wilcoxon signed-rank tests) in order to assess change over time. Small amounts of missing data 
(fewer than three items on any measure) were managed using imputation of the mean value of the 
other items on that scale or sub-scale. Larger amounts of missing data were managed by adopting a 
pairwise exclusion approach.   
 
Patient actors’ Likert scale responses were analysed with content analysis42 to identify categories in 
open-ended written responses. These categories were developed inductively from the data (i.e. 
using emergent rather than pre-determined ideas) and a researcher (LH) not involved in data 
collection independently second coded these data. Categories identified by the two coders were 
subsequently compared and ambiguities resolved via discussion.  
Intervention content and procedure  
The following description of the training intervention is consistent with the ‘Template for 
Intervention Description and replication (TIDier) guidelines43. The Pso Well® training programme was 
designed in line with current recommendations for psoriasis management43 and behaviour change 
methods33,45. Content was supplemented by additional recommendations from research team 
members involved in reviewing more up-to-date research evidence on psoriasis1,3,26,28-31,46,47. This 1-
day intensive training programme aimed to enable clinicians to adopt a patient-centred consultation 
approach and applied MI skills. Skills taught to clinicians addressed the core MI processes – Engaging, 
Focusing, Evoking, and Planning. The MI literature provides further detail on these principles48, and 
its evidence base33,35-39,49.  
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The 1-day face-to-face training session was delivered in private university/hospital training rooms 
and delivered by CB and AC for consistency; both are psychologists trained in MI and experienced in 
delivering MI-based workshops to a range of clinicians. During training, research was presented 
demonstrating the links between psoriasis and modifiable behavioural factors (i.e. smoking, alcohol, 
obesity, physical activity, low mood, and medication adherence). MI skill-building activities were 
presented using a consistent structure, namely: (a) learning about new skills; (b) watching skills 
demonstration; (c) individual skills practice; and (d) feedback or coaching on skills use. (Video link 
provides further training details: http://www.impactpsoriasis.org.uk/practitioners/). 
 
Embedded qualitative study  
A purposive sample of trainees, with a broad range of characteristics (e.g. profession, sex, training 
session attended) were invited to complete a semi-structured interview to explore their experiences 
and perceptions of the Pso Well® training. Invitations to interview were made face-to-face 
immediately following training and researchers (AC/CP) followed up to arrange interviews with 
those expressing interest. Interview topics focused on clinicians’ experiences and views of the 
training content, delivery, and assessment methods. Interviews were digitally audio-recorded, 
transcribed verbatim, and analysed using an inductive thematic analysis50. Supplementary File 1 
provides further detail on the methodological approach undertaken.   
RESULTS 
Recruitment 
Sixty-one clinicians attended training; it was not possible to identify exact numbers of clinicians 
invited to participate in the study due to third parties forwarding on invitations to whole 
organisation/membership lists. Of the 61 participants, six did not complete pre- and/or post-training 
audio-taped consultations. Three clinicians were unwilling to complete patient actor consultations 
due to low confidence in their anticipated performance, one clinician was absent post-training and 
two technical faults occurred. This resulted in five audio recordings being omitted from the analysis; 
these were instead used for training of the BECCI rater team. In total 110 audio-recordings were 
included in the BECCI analysis.  Training courses ran across the UK with between five and 15 
clinicians; of the 61 attendees, 53 were female (86.9%). Purposive sampling based on a range of 
characteristics (Table 1) resulted in 18 clinicians completing a post-training qualitative interview (17 
by telephone; one face-to-face).  
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Clinicians’ motivational interviewing skills   
A paired-samples t-test was conducted on the BECCI data to evaluate the impact of the Pso Well® 
training on clinicians’ (n=55) motivational interviewing skills. There was a statistically significant 
increase in BECCI scores from pre-training (M = .50, SD = .47) to post-training (M = 1.26, SD = .71), 
t(54) = 8.37, p < .001 (two-tailed). The mean increase in BECCI scores was .76 with a 95% confidence 
interval ranging from .57 to .94. The eta squared statistic of .56 indicated a large effect size regarding 
observed improvement in MI skills51.  
Figure 1 illustrates the mean BECCI scores before and after training. Figure 2 shows BECCI scores 
broken down by domain pre- and post-training. Percentages are calculated here because potential 
maximum total scores on each domain varied between 4 and 20 points.  
 
Table 2 displays descriptive data illustrating pre- and post-training BECCI scores organised by 
clinician group.  
Figure 3 illustrates mean clinician ‘talk time’ estimated by raters before and after attending the 
training. A paired-samples t-test was used to compare the proportion of the consultation time in 
which the clinicians spoke during patient-actor consultations before and after the Pso Well® training 
(n=55). There was a statistically significant decrease in talk time from pre-training (M = 58.36%, SD = 
15.93) to post-training (M = 47.18%, SD = 11.46), t(54) = 6.22, p < .001. The mean decrease in 
clinician talk time was 11.18% with a 95% confidence interval ranging from 7.58 to 14.79. The eta 
squared statistic (.42) indicated a large effect size51.  
 
Scores from the scale completed by patient actors indicated greater improvement in clinicians’ 
consultation approaches post training (Figure 4). The content analysis of actors’ open text responses 
identified differences in consultation approach before and after training. These differences are 
outlined in Table 3.  
 
Clinicians’ knowledge of psoriasis-related comorbidities and risk factors 
A paired-samples t-test was conducted on the survey data to assess the change in levels of clinicians’ 
knowledge following the Pso Well® training. Statistically significant increases were found for 
participants’ knowledge of risk factor prevalence (t(60) = 4.30, p < .001; pre-training  M = 5.82, 
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SD=1.21, post-training M = 6.47, SD=.93), as well as the mechanisms linking psoriasis and risk factors 
(t(60) = 7.12, p < .001; pre-training M = 11.52, SD=3.70, post-training M = 14.21, SD=3.66) but not 
regarding knowledge of psoriasis-related comorbidities (p = .096) (Figure 5).  
 
Table 4 displays descriptive data illustrating pre- and post-training knowledge scores categorised by 
clinician group (primary care clinician/dermatologist/specialist nurse). 
Figures 6 and 7 show the number and type of change topics discussed during audio-taped 
consultations, before and after training. A Wilcoxon signed-ranks test showed no significant 
difference (z = 1.32, p =.19) in the extent to which clinicians linked psoriasis and these change topics 
during consultations, pre and post training. This was measured using a single-item – ‘Did the clinician 
make links between psoriasis and behaviour change topics?’ 
 
Thematic analysis of qualitative interviews 
Five overarching themes accounted for clinicians’ experiences and views of the Pso Well® training: 
‘Delivery of the training’; ‘Utility of the training content’; ‘Skills acquisition and scope for 
implementation’; ‘Interest in and ability to attend’; and ‘Trade-offs when undergoing assessment’. 
Overall clinicians reported that the training enabled acquisition of novel consultation skills that were 
relevant and useful in the management of psoriasis. They highlighted the contrast between standard 
care and the more patient-centred/holistic approach used within the training. Clinicians also noted 
that for this approach to be fully embedded within their practice, they would require further 
coaching/feedback on their use of MI skills in practice. The full thematic structure alongside 
anonymised illustrative quotes from clinicians is illustrated in Supplementary File 2. 
 
DISCUSSION 
As understanding increases about how behavioural/psychological factors relate to psoriasis, so do 
calls for effective interventions targeting these factors52. The current findings show that the 1-day 
Pso Well® training programme enhanced clinicians’ ability to use MI skills to address behaviour 
change in the context of managing psoriasis. The degree of change in MI skills found in this study is 
equivalent to that demonstrated by other MI training53,54. Our previous work has shown that 
clinicians’ understanding about the relationships between psoriasis and related 
behavioural/psychological factors is limited and even when clinicians recognise psoriasis as a 
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complex condition, this understanding may not translate into clinical management approaches26. 
The Pso Well® training therefore aimed to integrate clinicians’ understanding and clinical 
management approach by providing them with evidence-based behaviour change strategies to use 
during standard psoriasis consultations. As well as demonstrating increased understanding of the 
links between psoriasis and lifestyle and mood factors, findings also showed that following training, 
clinicians discussed a broader range of these topics within consultations and focused conversations 
less on medications management alone. Patient actor feedback also illustrates (from a ‘proxy’ 
patient perspective) high levels of overall satisfaction with the consultation style used by clinicians 
following training that is consistent with core components of MI48: partnership (e.g. collaborative 
care); compassion (e.g. empathy, acknowledgement of people’s thoughts/feelings); and evocation 
(e.g. eliciting patient-led solutions and management plans).  
It was notable that following training clinicians’ knowledge of psoriasis-related comorbidities did not 
increase, nor were they more likely to explain to patients how psoriasis and behavioural factors are 
associated. This may have been because the training focused less on the relationships between 
psoriasis-associated conditions and behaviours per se, and more on how to address behaviour 
change with patients. Addressing behavioural factors as part of psoriasis management is important 
because modification of lifestyle factors, medication adherence and low mood can improve psoriasis 
outcomes and reduce the likelihood of developing or exacerbating psoriasis-related comorbidities55. 
Given that clinicians often don’t opportunistically or systematically discuss these issues with 
patients26,28,30-31, training such as Pso Well® is needed to support clinicians with this task. Despite not 
indicating an increase clinicians’ knowledge about psoriasis comorbidities, the Pso Well® training can 
change clinicians' approaches to psoriasis management discussions in line with current 
recommendations44. Moreover, this shift in approach can be carried out within the context of a 10-
minute consultation about psoriasis. Measuring the effects of this training intervention on patient 
outcomes within a controlled trial is now warranted.  
Consistent with the MRC guidance for complex intervention design32 this study also allowed us to 
explore the extent to which clinicians endorsed the training as relevant, useful, and usable within 
clinical practice. Qualitative findings indicate that the Pso Well® training is both feasible to conduct 
and evaluate within existing health care settings, and that clinicians are satisfied with the training 
content, delivery, and assessment methods chosen. 
Although the clinicians within this study were self-selected and thus potentially more skilled or 
predisposed to this approach56, baseline scores indicated little or no experience of using MI skills. 
This suggests that even those who were enthusiastic about or familiar with MI techniques, 
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benefitted from training. As the sample included mostly secondary care clinicians, the results cannot 
be generalised to the management of psoriasis by primary care professionals. Further work is 
necessary to explore the impact of this training on clinical management approaches to psoriasis 
conducted within general practice settings. Finally, recruitment to the training highlighted that 
secondary care clinicians are more likely to attend than GPs (with or without a special interest in 
dermatology). Barriers to engaging with, or attending this training should therefore be explored with 
this professional group.  
This study shows that the Pso Well® training programme can enhance standard clinical management 
of psoriasis to include an MI-consistent approach to addressing a range of psoriasis-related 
behavioural risk factors. Furthermore, it is likely that clinicians will engage with this training and find 
it useful for practice. The findings warrant further investigation of how this holistic approach to care 
could affect psoriasis outcomes within current clinical settings.   
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Table 1. Recruitment to the Pso Well® training programme and data collected from clinicians  
 
 
* Of the 23 dermatologists who attended the training, nine were dermatology specialist registrars 
 
 
 
 
 
 
Clinical specialism Attended Pso Well® 
training 
programme  
Completed 
skills 
measure 
Completed 
knowledge 
measure 
Completed 
qualitative 
interview 
Dermatologist 23 22 23 9 
Dermatology specialist nurse 35 31 34 8 
General Practitioner 
Health care assistant  
 
2 
1 
 
1  
1 
2  
1 
1 
0 
Total  61 55 60 18 
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Table 2. Mean BECCI scores grouped by participants’ health care discipline  
 
Clinician group  Mean BECCI 
score Pre (SD) 
Mean BECCI 
score post (SD) 
Mean 
change 
 
Dermatologist (consultant/registrar) 
N = 22 
 
Primary care clinician (GP, Health care assistant, 
primary care nurse) 
N = 6 
 
Nurse specialist (secondary care) 
N = 27  
.37 (.20) 
 
 
.51 (.39) 
 
 
 
.60 (.61) 
 
 
1.35 (.76) 
 
 
1.35 (.66) 
 
 
 
1.16 (.69)  
 
 
.98 
 
 
.84 
 
 
 
.56 
 
 
 
 
Table 3. Content analysis of patient actor feedback (n=55) 
 
Code label 
 
Illustrative quote(s) [clinician ID number] 
Before training 
 
 
Consultation 
approach 
Good rapport 
with patients 
Good, open, friendly, empathetic. (ID18)  Very kind and gentle consultation. (ID29) 
 
Non-judgemental 
approach 
She did not criticise my 'heaviness' which I thought made it easy to open up. (ID2) 
Lovely approach, non-judgemental. (ID37) 
 
Optimistic 
messages  
The nurse practitioner was very positive and offered me lots of hope to control the 
psoriasis. (ID2) 
 
Consultation 
focus 
Focused  upon 
clinicians’ agenda 
rather than 
patients’ 
Did not really ask about psycho-social situation until she picked up on cue at end. 
More the clinician's agenda. (ID19) 
Very 'practical', almost mechanical. Felt like there was a checklist being filled in. (ID4) 
 
Patient 
agenda/concerns 
unaddressed  
I felt the doctor listened and helpful but I would of liked to get into more of the things 
I'm struggling with. (ID30) 
I came away feeling like I didn't get a lot out and off my chest, there was much more I 
would have said if I was asked. (ID46) 
 
Narrow focus on 
disease/treatment  
Clinician's agenda was primarily to treat psoriasis condition. (ID14)  
Concentrated on treatments available rather than lifestyle change. Cues about weight 
not picked up. (ID31) 
 
Uncomfortable 
discussing lifestyle 
factors  
Only comfortable discussing all treatment options rather than addressing cues about 
lifestyle. (ID39) 
Listened to a few accounts of lifestyle then back to comfort zone of describing 
treatments. (ID37) 
 
Approach to 
management 
Lack of 
management 
Seemed unsure whether to commit to a course of action and if so which action it 
should be. (ID51) 
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Code label 
 
Illustrative quote(s) [clinician ID number] 
planning  planning Did not offer particular help. Commented only on my drinking habits. Time limitation 
prevented any constructive discussion. (ID21) 
 
Directive 
suggestion/ 
advice giving 
rather than 
patient-led 
Used phrases like "you need to do this"; "you must…" TOLD Sylvia to stop drinking. 
(ID24) 
I felt this clinician had a set view to tell me what could be offered and the risks which 
were off-putting…information giving only. (ID52) 
 
Advice giving 
rather than 
patient-focused 
 
 
 
 
 
 
 
 
I felt the doctor gave me lots of advice and stories of other people in my situation but 
I would have liked to talk a more about my problems and find more ways of dealing 
with it. (ID33) 
 
After training  
 
Consultation 
approach 
Noticeable 
improvement  
Lot better, asked really good questions, engaged fully, felt she cared about me and 
the future (ID17) 
Huge improvement! (ID14) 
 
Positive 
affect/satisfaction 
Had a lovely meeting with my doctor, felt I was given some really good ideas to help 
and was really listened to. Walked out of my consultation with a smile on my face. 
(ID30) 
 
Collaborative 
approach 
Great, thought she spoke to me not at me. Felt I was part of my future. (ID20) 
Asked: "What is the most important thing you want to address?" "We can take small 
steps" "Make the plan together". (ID28) 
 
Effective 
communication 
skills (empathy, open 
questions, reflections, 
engaged non-verbal 
communication)
Very different - the clinician shook hands and I felt more valued this time. Also 
showed empathy and understanding of my situation. (ID52) 
Lot more empathy, good listening skills, reacted to information, great open body 
language. (ID51) 
 
Consultation 
focus 
Patients’ agenda 
and concerns 
elicited 
All of my main worries and niggling problems were all brought to the surface. (ID41)   
Was very patient-centred 'what is my priority'. (ID19) 
 
Acknowledged 
patients’ thoughts 
and feelings 
Was able to talk more about her mood etc this time. Trainee much more empathic. 
(ID45) 
More acknowledgement of Sylvia's thoughts/feelings. (ID37) 
 
More focus on 
behaviour change 
Much more focus on lifestyle changes available and offering choices and ideas for 
weight loss and eating plan. (ID10) 
 
Linked psoriasis 
and lifestyle 
factors 
 
Did point out relationship between condition and BP/weight/cholesterol. (ID39) 
The doctor explained considerably more how my lifestyle might affect general health, 
including flare-ups. (ID8) 
Approach to 
management 
planning 
More focused on 
developing a plan 
from the 
discussion  
I got some good goals set out today to be thinking about for the next week what has 
put a smile on my face. I really liked how the doctor got my main worries from me 
and then formulated a plan for the future. (ID42) 
Felt she cared about me and the future. Started an action plan that could work for 
Joe. (ID17) 
 
Management 
discussion not 
Could of gone a little further with the planning being more constructive. (ID42) 
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Code label 
 
Illustrative quote(s) [clinician ID number] 
always led to 
change plans 
 
Patient-led 
solution finding  
Keen to help me to see ways I could help myself. (ID54) 
Cues re weight discussed extensively "what could you do about it", "what exercise 
would be suitable". (ID31)  
 
 
 
 
Table 4. Mean knowledge measure scores grouped by participants’ health care discipline  
 
Clinician group Mean 
Knowledge 
score Pre (SD) 
Mean 
Knowledge 
score post (SD) 
Mean 
change 
 
Nurse specialist (secondary care) 
N = 31  
 
20.51 (4.26) 24.00 (4.48) 3.48 
Dermatologist (consultant/registrar) 
N = 23 
 
21.76 (5.25) 24.67 (4.77) 2.91 
Primary care clinician (GP, Health care assistant, 
primary care nurse) 
N = 7 
22.71 (2.67) 25.29 (4.23) 2.57 
 
GP = general Practitioner  
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